Elfie is a free digital health super-app that combines self-monitoring tools, AI-driven coaching, gamification, and real-world rewards to help users manage chronic conditions. Launched in 2021, the app has grown to over 700,000 users across four continents and is available in 35 countries, with plans to expand to 10 more by the end of 2025. Elfie says its clinically validated interventions and behavioral-science approaches have driven 30%+ improvements in adherence for key pharmaceutical partners and measurable health improvements for users. The platform is medically approved across multiple regions and remains 100% free for users, with all revenue generated through enterprise partnerships. Elfie has secured multimillion-dollar partnerships with global pharma leaders and is piloting programs with global insurance carriers to reduce claim costs and loss ratios. The company plans to use new funding to accelerate user acquisition via pharma and insurance partnerships, expand its U.S. team (product, engineering, go-to-market), and launch Elfie Research, a decentralized clinical trial platform to generate real-world evidence. Elfie is a Singapore-based health monitoring platform that rewards patients for getting healthier. Its core product monitors health metrics and uses a rewards model to incentivize healthier behavior. Recent regulatory filings indicate the company has raised at least $4 million in fresh funding. The article cites those regulatory filings as the source of the funding information. No operating metrics, revenue figures, or future plans were disclosed in the article.

Total raised

$16M

Funding rounds

2

Latest round

Series A

Latest activity

Jun 2025